In what has become something of a tradition in recent years, yet another country has used the new year to adopt further laws related to...

Allergan’s lawsuit filed against the FDA presents a relatively novel case in addressing the requirements of drug developers in relation...

Following on from last week’s conversation, I left off with the issues surrounding the off-label prescriptive habits by physicians and...